ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

$5.07
+0.25 (+5.19%)
As of May 9, 1:40 AM ET ·
Day Range $4.88 — $5.08
52W Range $1.94 — $6.52
Open$4.93
Previous Close$4.82
Day High$5.08
Day Low$4.88
52W High$6.52
52W Low$1.94
Volume
Avg Volume10.17M
Market Cap1.46B
P/E Ratio
EPS$-0.49
SectorLife Sciences Tools & Services

Analyst Ratings

Strong Buy
14 analysts
12 Buy 2 Hold 0 Sell
Price Target +783.8% upside
Current
$5.07
Target
$44.81
$32.90 $44.81 avg $56.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 72.49M 135.01M 396.65M
Net Income -141,281,392 -236,828,558 43.78M
Profit Margin -194.9% -185.1% 11.0%
EBITDA -178,258,958 -315,414,434 99.33M
Free Cash Flow 67.30M
Rev Growth -46.3% -46.3% +18.5%
Debt/Equity 0.27

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $465.00 -1.99% 25.5 174.69B
DHR Danaher Corp $171.16 -2.56% 33.6 124.08B
A Agilent Technologies Inc $115.62 -2.55% 25.5 32.88B
IQV Iqvia Holdings Inc $178.71 +0.04% 20.3 27.54B
MTD Mettler-Toledo International $1,124.46 -14.77% 26.7 23.24B
WAT Waters Corp $355.13 +1.32% 53.5 34.38B

Next Earnings

May 11, 2026
After Market Close
0 days away
EPS Est: $-0.20

ABCL News

No news for ABCL yet

Quick Stats

Market Cap1.46B
P/E Ratio
EPS$-0.49
Volume
SectorLife Sciences Tools & Services